(Q73154679)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11064216%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

The use of different sugars as fine and coarse carriers for aerosolised salbutamol sulphate (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11064216%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

S K Tee

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11064216%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

C Marriott

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11064216%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

X M Zeng

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11064216%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

G P Martin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11064216%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 November 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11064216%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Pharmaceutics

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11064216%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

208

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11064216%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11064216%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

111-123

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11064216%20AND%20SRC:MED&resulttype=core&format=json

Modification of electrostatic charge on inhaled carrier lactose particles by addition of fine particles

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900553-6

7 January 2021

The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers--implications for in vitro testing.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900553-6

7 January 2021

Pharmaceutical dry powder aerosols: correlation of powder properties with dose delivery and implications for pharmacodynamic effect

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900553-6

7 January 2021

The twin impinger: a simple device for assessing the delivery of drugs from metered dose pressurized aerosol inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900553-6

7 January 2021

Pulmonary deposition of lactose carriers used in inhalation powders

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900553-6

7 January 2021

A new powder design method to improve inhalation efficiency of pranlukast hydrate dry powder aerosols by surface modification with hydroxypropylmethylcellulose phthalate nanospheres

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900553-6

7 January 2021

Protein deposition from dry powder inhalers: fine particle multiplets as performance modifiers

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900553-6

7 January 2021

Therapeutic aerosols 1--physical and practical considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900553-6

7 January 2021

Assessing lung deposition of inhaled medications. Consensus statement from a workshop of the British Association for Lung Research, held at the Institute of Biology, London, U.K. on 17 April 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900553-6

7 January 2021

Dry powder inhalers: the influence of device resistance and powder formulation on drug and lactose deposition in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900553-6

7 January 2021

Performance-Modifying Influences in Dry Powder Inhalation Systems

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900553-6

7 January 2021

The effect of the inhalation flow on the performance of a dry powder inhalation system

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900553-6

7 January 2021

Effects of particle size and adding sequence of fine lactose on the deposition of salbutamol sulphate from a dry powder formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900553-6

7 January 2021

The influence of carrier morphology on drug delivery by dry powder inhalers.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900553-6

7 January 2021

10.1016/S0378-5173(00)00553-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11064216%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference